마이클 돕스

Ahn Jae-yong

Ahn Jae-yong is the CEO of SK Bioscience.


After graduating from Yonsei University's Department of Economics, he completed his MBA at the University of Chicago Business School. He then joined SK Chemicals in 1998 after working at the Korea Trade Insurance Corporation.

He served as the head of SK Chemicals' strategic team, head of strategic planning office, and head of VAX's business division. He also led the launch of the world's first cell-culture influenza vaccine, 'SKYCellflu'.

 

SK Bioscience prepares for the future by developing a premium vaccine, while preparing for listing shares.

창닫기